ChartRow logo
BBIO
BridgeBio Pharma Inc.Stock · Health Care · Russell 2000 0.4%
$81.22−$2.62 (-3.13%)as of market close, Aug 13, 2026
☾ After hours:$81.21+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

BBIOBridgeBio Pharma Inc. stock price, chart and key statistics

Key stats#

Price data

Price
$81.22
Change YTD
+6.18%
Market cap
15.9B
Enterprise value
17.9B
Shares outstanding
195.5M
52W low
$46.81
52W high
$93.42
From 52W high
-13.05%
From 52W low
+73.51%
52W range
74%
Beta
0.98

Volume

Rel volume
0.02×
30D volume
2.9M
30D $ vol
247.5M

Fundamentals

Sales (ttm)
713.1M
Sales/share
$3.65
EPS (ttm)
-$3.62
FCF (ttm)
-435.4M
FCF/share
$-2.23
Book value/share
$-12.87
Net margin
-98.45%
ROA
-57.67%
Current ratio
1.23

Growth (CAGR, ttm) · 10Y

Sales
n/a
Net income
n/a
FCF
n/a
Shares
n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Sales/share
n/a
FCF/share
n/a
Book value/share
n/a
Price
n/a
Total return
n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

Fwd P/E
145.9×
22.3×
-6.3×
EV/Sales (ttm)
25.1×
-2.74%
-2.26%
-2.26%
1.32%
1.32%

Vs own 10Y history

P/S
20th

Bar = where today's multiple sits in BBIO's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return#

1D
-3.13%
1W
-1.91%
1M
-1.74%
3M
+18.38%
YTD
+6.18%
1Y
+65.45%
5Y
+44.70%

Financial statements

Open full BBIO financials →
1M
TickerThemePrice1M30D $Vol
NVS
Novartis AG
Health Care$152+0.59%268.9M
NVO
Novo Nordisk A/S
Health Care$46.73-7.58%555.7M
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Health Care$50.46-1.92%212.8M
SNY
Sanofi ADS
Health Care$43.78+0.23%142.5M
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Health Care$17.41+5.84%65M
ARGX
argenx SE American Depositary Shares
Health Care$857-0.66%251.9M
NTRA
Natera Inc.
Health Care$311+12.05%362.2M
RVMD
Revolution Medicines Inc.
Health Care$202+9.48%351.3M

BridgeBio Pharma Inc. (BBIO) trades at $81.22 with a live price and an interactive chart covering 7+ years of daily price history, plus key valuation metrics. ChartRow also publishes BBIO's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BBIO financial statements →